Skip to content

Follow-up of Patients' Physical Activity in Post-hospitalization

Follow-up of Patients' Physical Activity in Post-hospitalization by Implementation of Systems of Active Monitoring.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01822938
Acronym
TICAA'DOM
Enrollment
84
Registered
2013-04-04
Start date
2013-05-31
Completion date
2018-06-30
Last updated
2018-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

Physical exercise has been identified as a major item of many affecting many chronic diseases and stroke rehabilitation. It contributes to an improvement in the quality of life and to a decrease in the current treatment side-effects and mortality. Stroke in association with an inactive lifestyle lead to a decrease in physical capability and causes problems in daily activities. The physical capacity and the tolerance for exercise fall simultaneously leading to vicious circle of less and less mobility. Therefore, physical activity for the health is a valid and relevant way to improve the quality of life and to recover functional capacity. The aim of the study is the assessment of the effects of a incentive program for physical activity on people following/with stroke.

Interventions

OTHERincentive program for physical activity

Sponsors

University Hospital, Limoges
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Person having stroke (ischemic or hemorrhagic) * Whatever the area of stroke * Person supported by HEMIPASS (monitoring team and home support) * Stroke less than 6 months * Patient walking with or without technical or human assistance: FCC score

Exclusion criteria

* Disability limiting the gait before the stroke * Age \< 18 years * Cognitive impairment limiting participation to the program * Non signature of the consent * cardiopulmonary pathology which forbid/banned effort

Design outcomes

Primary

MeasureTime frame
The distance on the 6 minute walking test (6MWT)6 minutes

Secondary

MeasureTime frameDescription
Quality of lifeat 0 month, 6 months and 12 monthsEQ-5D

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026